youtube.com/live/rwP6yQOi4…

As the WHO prepares to adopt the Pandemic Agreement, equity in benefit-sharing is critical. Developing nations must have fair access to vaccines, therapeutics & data. India's proactive role can shape a just #PABS framework. #HealthForAll #PandemicPreparedness

A ray of hope for over 2 lakh SMA patients in India: Delhi HC allows Natco Pharma to develop a generic version of Risdiplam, potentially reducing treatment costs. deccanherald.com/health/spinal-…

The Trump administration is considering new tariffs on Chinese pharmaceutical imports, raising concerns about potential impacts on drug prices and supply chains. cnn.com/2025/06/03/bus…

‘India has scaled up its patent processing capacity’ deccanherald.com/india/india-ha… via @deccanherald

Seba & other Spinal Muscular Atrophy (SMA) patients are at the heart of a historic legal battle at the Delhi High Court. They are demanding access to life-saving medicine Risdiplam. 🧵1/6

From Rs350 to Rs50: India Slashes Sickle Cell Test Costs in Landmark Move bharatspeaks.com/from-rs350-to-…

Centre Plans To Restrict New TB Drugs To Govt Channels, Bar Private Sale news18.com/india/centre-p…

Plastic To Paracetamol: Scientists Convert Waste Into Painkiller In 24 Hours ndtv.com/science/plasti…